Novavax Inc. share price logo

Novavax Inc.

NASDAQ: NVAX

Small Cap

$9.37

+0.48

(+5.46%)

as on

Novavax Inc. Stock Performance

as on June 30, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $8.88
    $9.36
    downward going graph

    5.23%

    Downside

    -0.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.20
    $11.97
    downward going graph

    33.83%

    Downside

    27.75%

    Upside

    downward going graph

Novavax Inc. share price movements today

Previous Close
$8.88
Open
$8.93
Volume
3.4M
Day's Low - High
$8.88 - $9.36
52 Week Low - High
$6.20 - $11.97

Novavax Inc. Historical Returns

1 Month Return
-19.05 %
3 Month Return
+ 5.09 %
1 Year Return
+ 39.4 %
3 Year Return
+ 17 %
5 Year Return
-95.75 %

Novavax Inc. Stock Fundamentals & Key Indicators

Check Novavax Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-0.473

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.38%

PE Ratio (TTM)

0

PEG Ratio

1.3218

EBITDA

59.5M

Revenue (TTM)

596.3M

Profit Margin

-14.73%

Return On Equity TTM

-898.20%

Novavax Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novavax Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.5B-95.75%NA-14.73%NA
BUY$38.7B470.07%NA0.00%NA
BUY$38.9B75.66%73.0312.55%NA
BUY$124.7B149.69%29.1635.51%NA
BUY$66.4B15.92%15.4629.65%0.58%

Stock Returns calculator for Novavax Inc. Stock including INR - Dollar returns

The Novavax Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Novavax Inc. investment value today

Current value as on today

₹1,62,269

Returns

₹62,269

(+62.27%)

Returns from Novavax Inc. Stock

₹47,096 (+47.1%)

Dollar Impact

₹15,173 (+15.17%)

Analyst Recommendation on Novavax Inc. Stock

Based on 12 analysts

BUY

66.67%

Buy

16.67%

Hold

16.67%

Sell

Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Novavax Inc.. Average target price of $14.11

Novavax Inc. Share Price Target

Get share price movements and forecasts by analysts on Novavax Inc..

What analysts predicted

33.59%UPSIDE

Target Price

$14.11

Current Price

$9.37

Analyzed by

12 Analysts

Target

$14.11

Novavax Inc. target price $14.11, a slight upside of 33.59% compared to current price of $9.37. According to 12 analysts rating.

Indian Investors' Interest in Novavax Inc. Stock

Search interest for Novavax Inc. Stock has increased by 1% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1% versus previous 30 day period

Novavax Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
291
93
415
84
88
666
239
70
147
139
Gross Profit
142
45
369
23
51
652
225
48
121
108
Operating Income
-183
-138
160
-134
-131
515
105
-178
21
-15
EBITDA
-161
-129
179
-105
-53
533
120
-190
28
0
Interest Expense
4
4
4
4
7
5
5
5
5
4
Depreciation
10
12
11
12
12
8
7
6
5
3
Income Before Tax
-176
-145
164
-122
-73
519
107
-203
17
-8
Income Tax Expense
1
2
2
-1
7
1
0
0
0
0
Net Income
-178
-147
162
-121
-81
518
106
-202
17
-9
Net Profit Margin
-61.23%
-157.21%
39.08%
-143.53%
-91.76%
77.80%
44.52%
-287.29%
11.91%
-6.80%

Novavax Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
15
31
34
18
475
1,146
1,598
556
682
1,123
Gross Profit
-222
31
34
-95
475
1,146
696
212
479
1,052
Operating Income
-269
-171
-173
-120
-416
-1,686
-644
-566
-248
563
EBITDA
-260
-161
-165
-113
-411
-1,673
-604
-487
-108
492
Interest Expense
12
14
12
13
15
21
19
14
20
22
Depreciation
-
9
8
5
4
12
29
37
48
27
Income Before Tax
-279
-183
-184
-132
-418
-1,714
-653
-543
-176
442
Income Tax Expense
2
2
1
-2
9
29
4
2
10
1
Net Income
-279
-183
-184
-130
-427
-1,743
-657
-545
-187
440
Net Profit Margin
-1823.53%
-589.46%
-538.81%
-697.15%
-89.89%
-152.12%
-41.15%
-97.97%
-27.49%
39.19%

Novavax Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-147
162
-121
-81
518
106
-202
17
-9
Operating Cash Flow
-83
314
-144
-173
-185
-127
107
-39
-32
Investing Cash Flow
-7
-372
31
144
-73
111
-136
20
-28
Financing Cash Flow
5
258
0
-3
-7
-1
42
-6
37
Change in Cash
-87
199
-106
-43
-266
-9
14
-27
-23

Novavax Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-183
-184
-132
-418
-1,743
-657
-545
-187
440
Operating Cash Flow
-138
-184
-136
-42
322
-415
-713
-87
-244
Investing Cash Flow
35
28
38
-377
100
-92
-58
-204
-78
Financing Cash Flow
64
102
98
984
461
324
4
260
27
Change in Cash
-38
-53
0
566
879
-179
-765
-38
-289

Global Institutional Holdings in Novavax Inc.

Funds
Holdings
The Goldman Sachs Group Inc
0.86%
Citadel Advisors Llc
0.68%
TSP Capital Management Group/LLC
0.85%
Charles Schwab Investment Management Inc
0.84%
Jane Street Group LLC
0.61%

Novavax Inc. News & Key Events

  • img

    Today's Timeline - 26 February

    Thu, 06:10 PM

    -

    Novavax secures $30M upfront from Pfizer license and $330M credit facility to enhance liquidity.

    Thu, 06:36 PM

    -

    Novavax reports strong Q4 CY2025 results, beating revenue expectations with $147.1 million and EPS of $0.11.

    Fri, 01:53 AM

    -

    Novavax options show high volume, indicating significant trading interest in NVAX stock.

Insights on Novavax Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 393.3% return, outperforming this stock by 353.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 594.4% return, outperforming this stock by 577.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 147.13M → 139.51M (in $), with an average decrease of 5.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NVAX stock has moved down by -19.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 17.52M → -9.49M (in $), with an average decrease of 154.2% per quarter

About Novavax Inc.

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
OrganisationNovavax Inc.
Headquarters21 Firstfield Road, Gaithersburg, MD, United States, 20878
IndustryBiotechnology
CEOMr. John Charles Jacobs M.B.A.
E-voting on sharesClick here to vote

Key Management of Novavax Inc.

Name

Title

Ms. Elaine O'Hara

Executive VP & Chief Strategy Officer

Mr. Richard P. Crowley

Executive VP & COO

Luis Sanay C.F.A.

Vice President of Investor Relations

Mr. Ian J. Watkins

Executive VP & Chief Human Resources Officer

Ms. Silvia Taylor M.B.A.

Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden

Mr. John Charles Jacobs M.B.A.

President, CEO & Director

Mr. James Patrick Kelly C.F.A.

Executive VP, CFO & Treasurer

Mr. Mark J. Casey Esq., J.D.

Executive VP, Chief Legal Officer & Corporate Secretary

Mr. Troy Morgan Esq., J.D.

Senior VP, Deputy General Counsel & Chief Compliance Officer

Ms. Erika S. Trahan

Associate Director of Investor & Public Relations

FAQs

What is Novavax Inc. share price today?

Novavax Inc. share price today is $9.37 as on at the close of the market. Novavax Inc. share today touched a day high of $9.36 and a low of $8.88.

What is the 52 week high and 52 week low for Novavax Inc. share?

Novavax Inc. share touched a 52 week high of $11.97 on and a 52 week low of $6.2 on . Novavax Inc. stock price today i.e. is closed at $9.37,which is 21.72% down from its 52 week high and 51.13% up from its 52 week low.

What is Novavax Inc.'s market capitalisation today?

Novavax Inc. market capitalisation is $0.00T as on .

How to invest in Novavax Inc. Stock (NVAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Novavax Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novavax Inc. Shares that will get you 0.1601 shares as per Novavax Inc. share price of $9.37 per share as on June 30, 2026 at 1:29 am IST.

What is the minimum amount required to buy Novavax Inc. Stock (NVAX) from India?

Indian investors can start investing in Novavax Inc. (NVAX) shares with as little as ₹94.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.40 in Novavax Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Novavax Inc. share’s latest price of $9.37 as on June 30, 2026 at 1:29 am IST, you will get 1.0672 shares of Novavax Inc.. Learn more about fractional shares .

What are the returns that Novavax Inc. has given to Indian investors in the last 5 years?

Novavax Inc. stock has given -95.75% share price returns and 27% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?